[Federal Register Volume 86, Number 17 (Thursday, January 28, 2021)]
[Notices]
[Page 7392]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01888]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH), 
Subcommittee on Dose Reconstruction Review (SDRR), National Institute 
for Occupational Safety and Health (NIOSH); Correction

    Notice is hereby given of a change in the meeting of the Advisory 
Board on Radiation and Worker Health (ABRWH), Subcommittee on Dose 
Reconstruction Review (SDRR), National Institute for Occupational 
Safety and Health (NIOSH); February 25, 2021, 10:30 a.m. to 2:30 p.m., 
EST which was published in the Federal Register on December 23, 2020, 
Volume 85, Number 247, pages 83965-83966.
    The Matters to be Considered should read as follows:

SUPPLEMENTARY INFORMATION:
    Matters to be Considered: The agenda will include discussions on 
the following dose reconstruction program quality management and 
assurance activities: Dose reconstruction cases under review from Set 
28, possibly including cases involving, Rocky Flats Plant (RFP), 
Hanford, Los Alamos National Laboratory (LANL), Mound, Lawrence 
Livermore National Laboratory (LLNL), Savannah River Site (SRS), Oak 
Ridge National Laboratory (X-10), and Y-12 Plant. Dose reconstruction 
cases under review from Sets 14 through 21, possibly including cases 
involving, Uranium Mill in Monticello, GE Vallecitos, and Texas City 
Chemicals; and Tracking of decision points requiring professional 
judgement (time permitting). Agenda items are subject to change as 
priorities dictate.

FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated 
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24, 
Cincinnati, Ohio 45226, Telephone (513) 533-6800, Toll Free 1 (800) 
CDC-INFO, Email [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-01888 Filed 1-27-21; 8:45 am]
BILLING CODE 4163-18-P